Robert L. McNeil Jr., a third-generation pharmacist who in the 1950s played a crucial role marketing the new drug Tylenol, which was manufactured at his family's laboratory and has since become one of the world's bestselling over-the-counter painkillers, died of a heart ailment May 20 at his home in Wyndmoor, Pa. He was 94.

Mr. McNeil was a just out of pharmacy school in 1938 when he joined McNeil Laboratories, the Philadelphia-based company his grandfather had founded in 1879. Originally a neighborhood drugstore, it had morphed by then into a business marketing drugs directly to hospitals and doctors.

Almost immediately, Mr. McNeil was made responsible for evaluating the company's product line and establishing a research division to develop new prescription drugs, according the 2003 book "Pharmaceutical Achievers" by Mary Ellen Bowden, Amy Beth Crow and Tracy Sullivan.

In 1951, Mr. McNeil suggested that the company consider selling a little-known analgesic originally discovered in the 19th century that had only recently shown in rigorous studies to effectively reduce aches and fevers.

Advertise with us

Skeptics wondered whether there would be sales potential for such a painkiller given the already widespread use of aspirin, which was relatively cheap. Mr. McNeil prevailed after pointing out that the new analgesic would have none of aspirin's unpleasant side effects and could be marketed to different clients as a prescription drug.

Company scientists did additional laboratory testing of the drug to secure approval for its sale from the U.S. Food and Drug Administration. Mr. McNeil came up with the drug's generic name, acetaminophen. A colleague dubbed it Tylenol, an abbreviation of the chemical name, N-aceTYL-p-aminophENOL.

In 1955, Tylenol Elixir for Children hit the shelves in a box shaped like a fire engine with the slogan "for little hotheads."